LKB1 deficiency enhances sensitivity to energetic stress induced by erlotinib treatment in non-small-cell lung cancer (NSCLC) cells.
about
Circuits of cancer drivers revealed by convergent misregulation of transcription factor targets across tumor types.A Sensitive NanoString-Based Assay to Score STK11 (LKB1) Pathway Disruption in Lung Adenocarcinoma.Dependence On Glycolysis Sensitizes BRAF-mutated Melanomas For Increased Response To Targeted BRAF Inhibition.A data mining approach for identifying pathway-gene biomarkers for predicting clinical outcome: A case study of erlotinib and sorafenib.HPV16 E6/E7 upregulates HIF-2α and VEGF by inhibiting LKB1 in lung cancer cells.Functional characterization of AMP-activated protein kinase signaling in tumorigenesis.LKB1 promotes metabolic flexibility in response to energy stress.MEK inhibition enhances efficacy of bacillus Calmette-Guérin on bladder cancer cells by reducing release of Toll-like receptor 2-activated antimicrobial peptides.Long-term persistent infection of HPV 16 E6 up-regulate SP1 and hTERT by inhibiting LKB1 in lung cancer cells.Pyruvate kinase M knockdown-induced signaling via AMP-activated protein kinase promotes mitochondrial biogenesis, autophagy, and cancer cell survival.Drug screening to target nuclear orphan receptor NR4A2 for cancer therapeutics.Oncogene-Driven Metabolic Alterations in Cancer.Lactate Metabolism in Human Lung Tumors.Expression profiling and microRNA regulation of the LKB1 pathway in young and aged lung adenocarcinoma patients
P2860
Q36481398-E2319059-CD2A-4089-93D3-8A56619DE985Q36927481-2471D964-B098-470C-950C-D0D3C2AF39BAQ37644414-9009076D-2698-4975-B6C7-ED509B416247Q38632417-7BDB0324-4673-4571-8226-D5D5A7976144Q38696908-B0B515A6-5783-4A66-9A3F-B5BCC93A476EQ38807302-657ACF1C-92F7-4BEA-8DD3-C76CF19CD8C5Q39051999-A3644402-D4A7-4DA6-A9C9-D07278064B39Q40062396-908EC932-D195-46BD-9160-18ADE592F95DQ40091492-9573C506-A1A8-4FE8-AF67-91D0E346F20CQ41951381-F7FA2494-0DD9-48EC-8394-EB867FA82FB0Q45327788-27E1D768-0A29-47B8-9445-F638FEF69781Q47159555-EFBF43AD-D97A-485E-9B0D-2A0B82B57505Q47594603-8EED90AD-1175-4BBD-B18A-1977A12DC5F5Q57120202-752DF451-1A86-4550-83A8-699890CD7669
P2860
LKB1 deficiency enhances sensitivity to energetic stress induced by erlotinib treatment in non-small-cell lung cancer (NSCLC) cells.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
LKB1 deficiency enhances sensi ...... ell lung cancer (NSCLC) cells.
@ast
LKB1 deficiency enhances sensi ...... ell lung cancer (NSCLC) cells.
@en
type
label
LKB1 deficiency enhances sensi ...... ell lung cancer (NSCLC) cells.
@ast
LKB1 deficiency enhances sensi ...... ell lung cancer (NSCLC) cells.
@en
prefLabel
LKB1 deficiency enhances sensi ...... ell lung cancer (NSCLC) cells.
@ast
LKB1 deficiency enhances sensi ...... ell lung cancer (NSCLC) cells.
@en
P2093
P2860
P356
P1433
P1476
LKB1 deficiency enhances sensi ...... ell lung cancer (NSCLC) cells.
@en
P2093
D P Carbone
I A Trenary
J M Kaufman
J P Fessel
R A Egnatchik
P2860
P2888
P304
P356
10.1038/ONC.2015.140
P407
P50
P577
2015-06-29T00:00:00Z
P6179
1000928239